BC
ICCM icon

Bartlett & Co’s IceCure Medical ICCM Stock Holding History

Bartlett & Co’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed – – 1155
2023
Q2 		$0 Hold
8
– – ﹤0.01% 1138
2023
Q1 		$0 Hold
8
– – ﹤0.01% 1061
2022
Q4 		$0 Hold
8
– – ﹤0.01% 1127
2022
Q3 		$0 Hold
8
– – ﹤0.01% 1209
2022
Q2 		$0 Hold
8
– – ﹤0.01% 1293
2022
Q1 		$1K Buy
+8
New +$620 ﹤0.01% 1022

Other funds holding ICCM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bartlett & Co's ICCM Position: Q3 2023 in Review

Bartlett & Co sold out of IceCure Medical (ICCM) in Q3 2023, closing a stake of 8 shares.

Bartlett & Co first reported a position in ICCM in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 12 funds tracked by Wall St. Rank hold ICCM as of Q3 2023.

  • Bartlett & Co reported no remaining IceCure Medical position as of Q3 2023 after selling out during the quarter.
  • Bartlett & Co sold 8 IceCure Medical shares in Q3 2023.
  • Bartlett & Co first reported a position in IceCure Medical in Q1 2022 and held it in 6 quarters.
  • Bartlett & Co's IceCure Medical position peaked at $1K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2023.

Based on Bartlett & Co's 13F filing for Q3 2023, filed 10 Oct 2023.